Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2021

01-02-2021 | Eosinophilic Esophagitis | Original Article

Effect of Maintenance Therapy for Eosinophilic Esophagitis on Need for Recurrent Dilation

Authors: Daniel A. Schupack, Karthik Ravi, Debra M. Geno, Katrina Pierce, Kristin Mara, David A. Katzka, Jeffrey A. Alexander

Published in: Digestive Diseases and Sciences | Issue 2/2021

Login to get access

Abstract

Background

Eosinophilic esophagitis is an inflammatory condition in which eosinophil infiltration leads to esophageal remodeling and stricturing, with dilation therapy often needed. Achieving histologic remission reduces the need for repeat dilation, although little is known about the effects of long-term maintenance therapy.

Aims

To further assess the relationship between short-term histologic remission and maintenance therapy on need for repeat dilation in eosinophilic esophagitis.

Methods

A total of 77 patients with eosinophilic esophagitis (59.7% male; mean age 41.6 years) seen at a single medical center from June 2000 to August 2017 were included. Information on history of dilation and therapy [proton pump inhibitors (PPIs), steroids, elimination diet] was collected. Mean follow-up was 164 weeks. Fifty-one patients achieved histologic remission and 42 of these remained on maintenance therapy (23 PPIs, 14 topical steroids, and 5 dietary therapy). Standard phone interview was completed in cases with lack of follow-up. Only patients who underwent esophageal dilation to ≥ 17 mm were included.

Results

A significantly lower proportion of patients on maintenance therapy required repeat dilation (12/42) compared with patients not on maintenance therapy (8/9) (hazard ratio 0.12; p < 0.001). Of patients who received maintenance therapy, 9.1% required re-dilation. The difference in need for repeat dilation in patients who achieved histologic remission on therapy (14/26) versus those who did not (20/51) was not significant (hazard ratio 1.34; p = 0.45).

Conclusion

In a retrospective analysis of patients with eosinophilic esophagitis, we found that a significantly lower proportion who received maintenance therapy (PPIs, steroids, or dietary exclusions) required repeat dilation.
Literature
1.
go back to reference Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statement and recommendations for diagnosis in children and adults. United Eur Gastroenterol J. 2017;5:335–358.CrossRef Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statement and recommendations for diagnosis in children and adults. United Eur Gastroenterol J. 2017;5:335–358.CrossRef
2.
go back to reference Carlson DA, Hirano I, Zalewski A, Gonsalves N, Lin Z, Pandolfino JE. Improvement in esophageal distensibility in response to medical and diet therapy in eosinophilic esophagitis. Clin Transl Gastroenterol. 2017;8:e119.CrossRef Carlson DA, Hirano I, Zalewski A, Gonsalves N, Lin Z, Pandolfino JE. Improvement in esophageal distensibility in response to medical and diet therapy in eosinophilic esophagitis. Clin Transl Gastroenterol. 2017;8:e119.CrossRef
3.
go back to reference Lee J, Huprich J, Kujath C, et al. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012;10:481–486.CrossRef Lee J, Huprich J, Kujath C, et al. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012;10:481–486.CrossRef
4.
go back to reference Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105:1062–1070.CrossRef Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105:1062–1070.CrossRef
8.
go back to reference Nicodème F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11:1101–1107.CrossRef Nicodème F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11:1101–1107.CrossRef
9.
go back to reference Kuchen T, Straumann A, Safroneeva E, et al. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. Allergy. 2014;69:1248–1254.CrossRef Kuchen T, Straumann A, Safroneeva E, et al. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. Allergy. 2014;69:1248–1254.CrossRef
10.
go back to reference Runge TM, Eluri S, Woosley JT, Shaheen NJ, Dellon ES. Control of inflammation decreases the need for subsequent dilation in patients with eosinophilic esophagitis. Dis Esophagus. 2017;30:1–7.CrossRef Runge TM, Eluri S, Woosley JT, Shaheen NJ, Dellon ES. Control of inflammation decreases the need for subsequent dilation in patients with eosinophilic esophagitis. Dis Esophagus. 2017;30:1–7.CrossRef
11.
go back to reference Greuter T, Alexander JA, Straumann A, Katzka DA. Diagnostic and therapeutic long-term management of eosinophilic esophagitis-current concepts and perspectives for steroid use. Clin Transl Gastroenterol. 2018;9:e212.CrossRef Greuter T, Alexander JA, Straumann A, Katzka DA. Diagnostic and therapeutic long-term management of eosinophilic esophagitis-current concepts and perspectives for steroid use. Clin Transl Gastroenterol. 2018;9:e212.CrossRef
12.
go back to reference Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155:1022–1033.CrossRef Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155:1022–1033.CrossRef
15.
go back to reference Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smouth AJPM, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836–844.CrossRef Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smouth AJPM, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836–844.CrossRef
16.
go back to reference Lucendo AJ, Molina-Infante J. Esophageal dilation in eosinophilic esophagitis: risks, benefits and when to do it. Curr Opin Gastroenterol. 2018;34:226–232.CrossRef Lucendo AJ, Molina-Infante J. Esophageal dilation in eosinophilic esophagitis: risks, benefits and when to do it. Curr Opin Gastroenterol. 2018;34:226–232.CrossRef
17.
go back to reference Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011;73:15–21.CrossRef Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011;73:15–21.CrossRef
18.
go back to reference Dougherty M, Runge TM, Eluri S, Dellon ES. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86:581–591.CrossRef Dougherty M, Runge TM, Eluri S, Dellon ES. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86:581–591.CrossRef
19.
go back to reference Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic esophagitis. Aliment Pharmacol Ther. 2017;46:96–105.CrossRef Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic esophagitis. Aliment Pharmacol Ther. 2017;46:96–105.CrossRef
20.
go back to reference Podboy A, Katzka DA, Enders F, et al. Oesophageal narrowing on barium oesphagram in more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia. Aliment Pharmacol Ther. 2016;43:1168–1177.CrossRef Podboy A, Katzka DA, Enders F, et al. Oesophageal narrowing on barium oesphagram in more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia. Aliment Pharmacol Ther. 2016;43:1168–1177.CrossRef
Metadata
Title
Effect of Maintenance Therapy for Eosinophilic Esophagitis on Need for Recurrent Dilation
Authors
Daniel A. Schupack
Karthik Ravi
Debra M. Geno
Katrina Pierce
Kristin Mara
David A. Katzka
Jeffrey A. Alexander
Publication date
01-02-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06192-8

Other articles of this Issue 2/2021

Digestive Diseases and Sciences 2/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.